🔎 Trials Near Me

Hjem › Juvenil myelomonocytisk leukemi › District of Columbia

Kliniske studier for Juvenil myelomonocytisk leukemi i District of Columbia

3 studier for Juvenil myelomonocytisk leukemi søker deltakere på steder i District of Columbia.

Byer i District of Columbia

Offisiell studietekst (engelsk)

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

  • Children's National Medical Center, Washington D.C.
RekruttererFase 1/2
1 Month – 21 Years · Alle kjønn · Oppdatert 4. sep. 2026 · NCT05849662

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

  • Children's National Medical Center, Washington D.C.
RekruttererFase 1
Alder 1 til 18 · Alle kjønn · Oppdatert 25. aug. 2026 · NCT06247787

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

  • Children's National Medical Center, Washington D.C.
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.